This Protocol Focuses on the Factors That Influence Survival, the Development of Complications and the Quality of Life Based on the Treatment Received in the Group of Patients Suffering From Malignant Lesions of the Head and Neck
Condition(s) studied
Investigational drug(s) / intervention(s)
treatment received in the group of patients suffering from malignant lesions of the head and neck.: This protocol focuses on a retrospective, single-center analysis, analyzing the factors that influence survival as the main objective, and secondarily the development of complications and the quality of life based on the treatment received in the group of patients suffering from malignant lesions of the head and neck.
Study summary
This protocol focuses on a retrospective, single-center analysis, analyzing the factors that influence survival as the main objective, and secondarily the development of complications and the quality of life based on the treatment received in the group of patients suffering from malignant lesions of the head and neck.
Eligibility
Primary outcome measure(s)
- Overall Survival (OS) in Patients with Head and Neck Malignancies Treated with Curative Intent — 5 years
To assess overall survival in patients with malignant lesions of the head and neck (oral cavity, oropharynx, hypopharynx, larynx) undergoing curative treatment. Treatment modalities include major oncological surgery (alone or followed by adjuvant radiotherapy ± chemotherapy), definitive radiotherapy, definitive chemoradiotherapy, or induction chemotherapy followed by surgery or radiotherapy. Time Frame: 5 years from treatment initiation Unit of Measure: Time (months)
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Ospedale San Raffaele | Milan | Italy |
More IRCCS San Raffaele trials in Italy
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07066878 on ClinicalTrials.gov ↗ ← All trials in Italy